You are here: Industry Insights > Market News

Market News

InnoCare Releases 2025 Interim Results and Business Highlights PharmaSources
August 20, 2025
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2025 interim results as of 30 June 2025.
Alzheimer’s Disease: Charting the Course from Plaques to Promise Muhammad Farhan Khalid
May 28, 2025
New Tools，New Hope，New Frontier
Henlius Licenses Phase 3 Innovative HER2 ADC from GeneQuantum Henlius
August 20, 2025
Recently, Shanghai Henlius Biotech, Inc. (2696.HK) has entered into a strategic collaboration with GeneQuantum Healthcare (Suzhou) Co., Ltd. ("GeneQuantum").
Everest Medicines Expands Strategic Investment in I-MAB to Advance the Global Value of Its Proprietary Next-Generation Cancer Immunotherapies ACN Newswire
August 02, 2025
Everest Medicines (HKEX: 1952.HK) today announced a strategic equity investment in I-Mab (NASDAQ: IMAB), under which Everest will invest US$30.9 million (equivalent to approximately HK$242.6 million) in cash.
Eviva Partners Launches New Think Tank, Exposes Attack on Aluminum-Containing Vaccines PR Newswire
July 31, 2025
Eviva Partners, a nonprofit organization dedicated to strengthening public understanding of medical evidence, is proud to announce the launch of Protecting Our Health (POH).
Dx&Vx Signs USD 220 Million Co-Development and License Agreement for mRNA Cancer Vaccine with U.S. Biotech Company PR Newswire
July 31, 2025
Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment.
Emerald Clinical Trials Confirms CEO Transition and Continuity Plan PR Newswire
July 30, 2025
Emerald Clinical Trials, a leading global clinical research organization, today announced a leadership transition.
From the Alzheimer's Association International Conference 2025: SNAP Benefits Linked to Slower Cognitive Decline, 10-Year Study Finds. PR Newswire
July 30, 2025
Participating in the Supplemental Nutrition Assistance Program (SNAP) may help protect against age-related cognitive decline, suggests an analysis of a national study.
Touchlight Introduces mbDNA?: A “Best-In-Class" Circular Single Stranded DNA (ssDNA) Platform Enabling Superior Gene Editing Biotech Newswire
July 30, 2025
Touchlight, a pioneer in cell-free DNA innovation, is proud to announce the commercial launch of their new technology for non-viral gene editing, mbDNA?.
Telix H1 2025 Results: Investor Webcast Notification PR Newswire
July 30, 2025
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that it will release its financial results for the half-year ended 30 June 2025 on Thursday 21 August 2025.